|
EWTX Edgewise Therapeutics Inc 1710072 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-49,013,000.00 |
| Balance Sheet |
|
Current Assets
|
$509,792,000.00 |
|
Assets
|
$518,522,000.00 |
|
Current Liabilities
|
$22,543,000.00 |
|
Liabilities
|
$25,319,000.00 |
|
Equity
|
$493,203,000.00 |
|
Shares Out
|
107481522.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-42,543,000.00 |
|
Investing Cash Flow
|
$2,433,000.00 |
| Market Analysis |
Market Cap
|
$4,419,640,184.64 |
|
Price
|
$37.42 |
|
BVPS
|
4.59 |
|
PB
|
8.96 |
|
EPS
|
-0.46 |
|
FCF
|
$-42,803,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:20 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:15 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.47 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.46 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-0.34 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-0.39 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view EWTX documents filed with the SEC.
EWTX Filings
Clear
